Skip to main content
Equibles

AMERICAN CENTURY COMPANIES INC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 748054 KANSAS CITY, MO
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,846,532
+$798,772 QoQ
Shares Held
156,317
+8.5% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 183 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. CGEM ranks #65 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,853,956 $558,096,374
2 ASND
Ascendis Pharma A/S
 1,400,575 $373,561,364
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 580,901 $288,550,953
4 ARGX
Argenx SE
 173,193 $160,683,269
5 IONS
Ionis Pharmaceuticals Inc
 1,947,076 $154,383,656
6 EXEL
Exelixis, Inc.
 1,791,664 $97,484,438
7 HRMY
Harmony Biosciences Holdings, Inc.
 2,539,512 $92,463,631
8 GPCR
Structure Therapeutics Inc.
 1,682,179 $90,282,546

All Filings in CGEM

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,846,532 156,317
2026-03-31 $2,047,760 144,107
2025-12-31 $1,477,576 142,761
2025-09-30 $836,539 141,069
2025-06-30 $942,673 125,189
2025-03-31 $852,911 112,670
2024-12-31 $1,226,781 100,721
2024-09-30 $1,518,502 90,711
2024-06-30 $1,325,753 76,018
2024-03-31 $974,313 57,178
2023-12-31 $422,406 41,453
2023-09-30 $2,650,319 292,853
2023-06-30 $3,341,119 310,513
2023-03-31 $3,303,553 322,928
2022-12-31 $2,809,180 266,273
2022-09-30 $1,013,087 79,024